The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Tuesday, January 10, 2023
Novavax, Inc. announced that John C. Jacobs will succeed Stanley C. Erck as President and Chief Executive Officer and a member of the Board of ...
read more
Santhera Pharmaceuticals and ReveraGen BioPharma, Inc. announced that the FDA accepted the new drug application (NDA) for vamorolone for the treatment...
read more
Amneal Pharmaceuticals, Inc. has signed a long-term license agreement with Orion Corporation to commercialize a number of Amneal’s complex generic ...
read more
Orchard Therapeutics announced the FDA cleared its Investigational New Drug (IND) application for OTL-203, a hematopoietic stem cell (HSC) gene ...
read more
Synaffix B.V. announced the signing of a licensing agreement with Amgen to develop next generation ADCs.
read more
Alvotech and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced that the FDA accepted for review a Biologics ...
read more
UCB announced that the FDA accepted the company's filing to review a Biologic License Application (BLA) for its investigational treatment ...
read more
Friday, December 30, 2022
Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, and Abiosciences, the single-cell bioinformatics leader, ...
read more
Friday, December 30, 2022
Everest Medicines, a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, ...
read more
Thursday, December 29, 2022
Harm Reduction Therapeutics (HRT), Inc., a 501(c)(3) nonprofit pharmaceutical company whose mission is to prevent opioid overdose deaths by making ...
read more
Friday, December 16, 2022
AbbVie has submitted a supplemental New Drug Application (sNDA) for linaclotide (LINZESS®) FDA to treat children and adolescents 6 to 17 years of age ...
read more
Friday, December 16, 2022
Now in its 20th year! The bioindustry's most in-depth, global benchmarking and analysis study: Your input is important as we benchmark current global ...
read more
Thursday, December 15, 2022
Discovery Life Sciences™ announced the launch of its new Proteomic Services Division and is now accepting samples from pharmaceutical and biotech ...
read more
Wednesday, December 14, 2022
Takeda will acquire NDI-034858 from Nimbus Therapeutics. NDI-034858 is an oral, selective allosteric tyrosine kinase 2 (TYK2) inhibitor being ...
read more
Tuesday, December 13, 2022
ADMA Biologics, Inc. announced the FDA approval for its supplemental Biologics License Applications (BLAs) for both ASCENIV and BIVIGAM to now include...
read more